0.5 CPD learning hours
Effect of Bifidobacterium longum 35624® on irritable bowel syndrome severity and quality of life. Results of the Floravie observational study with Prof Jean-Marc Sabate
In this short webinar recorded for the 2021 British Society of Gastroenterology Annual Meeting, Prof Eamonn Quigley provides an update on definitions and pathophysiology associated with functional gastrointestinal disorders (FGIDs), and the latest research on probiotics for brain and gut health.
Understand how symptom severity is measured in those with IBS according to Rome IV criteria
Understand the impact of Bifidobacterium longum 35624® on quality of life in those with IBS
Understand how stool transit is changed with the introduction and continued use of probiotics
Understand the role of probiotics as potential therapeutic strategy for improving quality of life and symptom severity in patients with IBS
Recommended for you…